Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 710 of 6351
-
Could 3 chemo rounds be enough? new trial aims to cut treatment burden
Disease control Recruiting nowMulticenter, randomized, open label study including patients with advanced HRDpositive high-grade ovarian cancer, fallopian tube cancer, primary peritoneal cancer and clear cell carcinoma of the ovary with no residual tumor mass following primary tumor debulking to determine recu…
Phase 2 • Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug duo aims to tame Graft-Versus-Host disease
Disease control OngoingThis study will be conducted to determine the preliminary efficacy of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with cGVHD.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Stroke recovery: which blood pressure target works best?
Disease control Recruiting nowSeveral clinical trials have produced variable conclusions regarding the effects of intensive blood pressure (BP) lowering in post-EVT acute ischaemic stroke (AIS) patients. Although two trials indicate harm from very intensive target-based treatment (SBP \<130 mmHg), the others …
Sponsor: The George Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can genes explain sudden cardiac death in young athletes?
Knowledge-focused Recruiting nowThe increased risk of sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to vigorous physical activity is well-documented. Currently, for young victims (under 35 years) of SCA/SCD, no etiology is found in 40 to 50% of cases after a standard medical assessment, lead…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Can a gentler injection schedule straighten the curve in Peyronie's disease?
Disease control OngoingOur team has previously demonstrated efficacy in performing a novel collagenase Clostridium histolyticum (CCH) injection protocol in men who previously failed to achieve a response to an initial 4 series of CCH. The objective of the current study is to evaluate a protocol that i…
Phase 4 • Sponsor: Charitable Union for the Research and Education of Peyronie's Disease • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New pill targets HER2 cancers in phase 2 trial
Disease control Recruiting nowThis is a study for people with advanced cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with HER2 alterations can join the study. The purpose of this study is to find out whether a medicine called zongertinib helps people with …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Exercise prescription: a new weapon against stroke?
Prevention OngoingThe objective of this study is to evaluate the effectiveness and safety of regular physical exercise in preventing ischemic stroke events in patients with symptomatic intracranial arterial stenosis.
Phase 3 • Sponsor: Capital Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Heart attack prevention showdown: smart imaging vs. pills alone
Disease control Recruiting nowThe overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a simple swab catch uterine cancer before it spreads?
Diagnosis Recruiting nowThe study goal is to investigate a non-invasive approach to predict endometrial cancer (EC) risk, better understand disease progression and identify opportunities for intervention. This two-part case-cohort prospective study will recruit patients whose abnormal uterine bleeding …
Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New hope for tough brain tumors: drug combo trial launches
Disease control Recruiting nowThis study is a prospective, single-arm clinical trial aimed at evaluating the safety and efficacy of ivoximab combined with temozolomide in the treatment of relapsed/refractory glioma. The study plans to enroll 29 patients with relapsed/refractory glioma. After signing informed …
Phase 1/2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to tame lupus flares
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of IMC-002 and IMM0306S in the treatment of active SLE.
Phase 1/2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a cheap vitamin shield the aging brain during heart surgery?
Disease control Recruiting nowThe purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduc…
Early phase 1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could shock waves boost botox for Stroke-Related foot stiffness?
Symptom relief OngoingSpastic equinovarus foot is the most common lower limb motor impairment after stroke and has a significant impact on gait, mobility, and quality of life. Botulinum toxin type A (BoNT-A) is considered the first-line treatment for focal post-stroke spasticity. Extracorporeal shock …
Sponsor: María Belén Martínez Luna • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can tiny zinc particles stop a deadly hospital superbug?
Knowledge-focused CompletedA. baumannii is known as the most frequently isolated organism in intensive care units (ICUs), causing a variety of nosocomial infections, including pneumonia, urinary tract infections (UTIs), bacteremia as well as skin and soft tissue infections. These infections are usually ass…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can olive oil and walnuts shield the brain from stroke and memory loss?
Disease control Recruiting nowThe study is divided into two phases: Phase 1 (observational) and Phase 2 (dietary intervention). The goal of Phase 1 is to assess the nutritional status and dietary habits of two cohorts of patients with CADASIL and CAA. A specific aim is to evaluate adherence to the Mediterrane…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug could soothe uncontrollable itch in rare skin condition
Symptom relief OngoingThe purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Phase 3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Smart AI could slash unnecessary prostate biopsies
Diagnosis CompletedProstate-specific antigen (PSA) testing has limited specificity for prostate cancer diagnosis, leading to a high rate of unnecessary biopsies. This multi-center study aims to develop and validate a non-invasive, multi-modal artificial intelligence model that combines cell-free DN…
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New drug acolbifene takes on tamoxifen in breast cancer prevention trial
Prevention Recruiting nowThis phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing breast cancer. The usual approach for patients at increased risk for breast cancer is to undergo yearly breast magnetic …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
Gene therapy targets second eye in rare blindness disorder
Disease control OngoingThe purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis pigmentosa.
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New pill aims to stop the itch of prurigo nodularis
Disease control OngoingThe purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC